Eli Casdin's Net Worth
$6.05 Million
Who is Eli Casdin?
Eli Casdin has an estimated net worth of $6.05 Million. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, Fulcrum Therapeutics, Inc., BIOLIFE SOLUTIONS INC, MAXCYTE, INC., STANDARD BIOTOOLS INC., GeneDx Holdings Corp., 2seventy bio, Inc., Generation Bio Co., Tenaya Therapeutics, Inc., SomaLogic, Inc., EXACT SCIENCES CORP, Absci Corp, Century Therapeutics, Inc., and CM Life Sciences III Inc..
SEC CIK
Eli Casdin's CIK is 0001534264
Past Insider Trading and Trends
2022 was Eli Casdin's most active year for acquiring shares with 14 total transactions. Eli Casdin's most active month to acquire stocks was the month of May. 2024 was Eli Casdin's most active year for disposing of shares, totalling 7 transactions. Eli Casdin's most active month to dispose stocks was the month of December. 2022 saw Eli Casdin paying a total of $79,182.06 for 542,195 shares, this is the most they've acquired in one year. In 2023 Eli Casdin cashed out on 146,464 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
STANDARD BIOTOOLS INC. (LAB) Snapshot price: $1.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.46% | 250K |
$2.19 | $546,750.00 | 54.03M |
Aug 27
| |||
Form 4
| +0.70% | 750K |
$2.09 | $1,546,237.01 | 107.4M |
Aug 22 - Aug 26
| |||
Form 4
| +2.37% | 1.2M |
$1.59 | $1,913,520.00 | 51.78M |
Aug 14
| |||
Form 4
| +3.22% | 1.58M |
$1.62 | $2,559,641.38 | 50.58M |
Aug 9 - Aug 13
| |||
Form 4
| +1.11% | 1.07M |
$1.61 | $1,718,800.82 | 97.43M |
Aug 7 - Aug 8
| |||
Form 4
| +0.06% | 1.59K |
—
|
—
| 2.75M |
Jul 19
| |||
Form 4
| +1.59% | 43.13K |
—
|
—
| 2.75M |
Jun 28
| |||
Form 4
|
—
|
0
|
$2.05 |
—
| 47.28M |
Jun 18
| |||
Form 4
| +0.22% | 100K |
$2.60 | $260,000.00 | 46.08M |
May 23
| |||
Form 4
| +1.32% | 600K |
$2.57 | $1,541,795.00 | 45.98M |
May 20 - May 22
| |||
Form 4
| +3.07% | 1.35M |
$2.56 | $3,455,543.67 | 45.38M |
May 15 - May 17
| |||
Form 4
| +404.12% | 46.47M |
$2.75 | $127,780,009.50 | 57.96M |
Mar 18
| |||
Form 4
| +2.24% | 251.4K |
$2.57 | $646,168.85 | 11.5M |
Mar 4 - Mar 5
| |||
Form 4
| +28.23% | 22.8K |
$2.50 | $57,000.00 | 103.56K |
Feb 20
| |||
Form 4
| +29,458.26% | 21.55M |
—
|
—
| 21.62M |
Jan 5
| |||
Form 4
| +56.40% | 26.38K |
—
|
—
| 73.14K |
Jun 14
| |||
Form 4
|
∞
| 1.2M |
$2.19 | $2,631,335.00 | 1.2M |
May 17 - May 19
| |||
Form 4
| +195.02% | 30.91K |
—
|
—
| 46.77K |
Jun 15
| |||
Form 4
|
∞
| 15.85K |
—
|
—
| 15.85K |
Apr 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SomaLogic, Inc. (SLGC) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -19.41M |
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +100.00% | 3.43K |
—
|
—
| 6.86K |
Mar 17
| |||
Form 4
| +2.17% | 215.19K |
—
|
—
| 10.13M |
Sep 29
| |||
Form 4
|
∞
| 3.43K |
—
|
—
| 3.43K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
| +81.69% | 19.19M |
$10.00 | $25,000,000.00 | 42.68M |
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CONSTELLATION PHARMACEUTICALS INC No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 771.41K |
$15.00 |
—
| 771.41K |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 604.28K |
$15.84 |
—
| 604.28K |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXACT SCIENCES CORP (EXAS) Snapshot price: $59.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +40.85% | 2.56K |
—
|
—
| 8.82K |
Jul 23
| |||
Form 4
|
∞
| 450 |
—
|
—
| 450 |
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
|
∞
| 6.26K |
—
|
—
| 6.26K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||